Synvolux manufactures and markets products for highly efficient, non-viral delivery of macromolecules, such as DNA, RNA, and protein/peptides. Its proprietary technology (SAINT™) is used worldwide under various brand names and is based on synthetic cationic lipids with proven safety and broad applicability both in vitro and in vivo. Synvolux welcomes partners interested in using SAINT™ lipids for various therapeutic applications.